Plasma NLRC4 and NLRP3 as potential diagnostic biomarkers for non-small cell lung cancer in pulmonary tuberculosis
Plasma NLRC4 and NLRP3 levels are promising biomarkers for distinguishing NSCLC in TB patients, with their combined use enhancing diagnostic accuracy in specific patient groups.
Authors
- Jun Ma (ORCID: https://orcid.org/0000-0002-1796-8283)
- Haiyan Cui (ORCID: https://orcid.org/0000-0003-4969-4835)
- Yunlu Gu
- Chenlei Cai
- Jian Ni (ORCID: https://orcid.org/0000-0003-4926-996X)
- Wei Sha (ORCID: https://orcid.org/0000-0002-2099-8205)
- Jia‐Wei Yang (ORCID: https://orcid.org/0000-0002-3590-6350)
- Mengting Xiong
- Shuanshuan Xie
Institutions
- Tongji University (CN)
- Shanghai Pulmonary Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1007/s12672-025-02753-3
- Citations
- 2
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality